These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 1629304

  • 1. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.
    Barilero I, Gandia D, Armand JP, Mathieu-Boué A, Ré M, Gouyette A, Chabot GG.
    J Chromatogr; 1992 Mar 27; 575(2):275-80. PubMed ID: 1629304
    [Abstract] [Full Text] [Related]

  • 2. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies.
    Escoriaza J, Aldaz A, Castellanos C, Calvo E, Giráldez J.
    J Chromatogr B Biomed Sci Appl; 2000 Apr 14; 740(2):159-68. PubMed ID: 10821401
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials.
    Chabot GG, Abigerges D, Catimel G, Culine S, de Forni M, Extra JM, Mahjoubi M, Hérait P, Armand JP, Bugat R.
    Ann Oncol; 1995 Feb 14; 6(2):141-51. PubMed ID: 7786822
    [Abstract] [Full Text] [Related]

  • 4. High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasma.
    Sumiyoshi H, Fujiwara Y, Ohune T, Yamaoka N, Tamura K, Yamakido M.
    J Chromatogr B Biomed Appl; 1995 Aug 18; 670(2):309-16. PubMed ID: 8548021
    [Abstract] [Full Text] [Related]

  • 5. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous quantification of Camptosar and its metabolite SN-38 in mouse plasma and tissues.
    Bardin S, Guo W, Johnson JL, Khan S, Ahmad A, Duggan JX, Ayoub J, Ahmad I.
    J Chromatogr A; 2005 May 06; 1073(1-2):249-55. PubMed ID: 15909526
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of CPT-11 in rhesus monkeys.
    Inaba M, Ohnishi Y, Ishii H, Tanioka Y, Yoshida Y, Sudoh K, Hakusui H, Mizuno N, Ito K, Sugiyama Y.
    Cancer Chemother Pharmacol; 1998 May 06; 41(2):103-8. PubMed ID: 9443622
    [Abstract] [Full Text] [Related]

  • 7. Determination by liquid chromatography with fluorescence detection of total 7-ethyl-10-hydroxy-camptothecin (SN-38) in beagle dog plasma after intravenous administration of liposome-based SN-38 (LE-SN38).
    Guo W, Ahmad A, Khan S, Dahhani F, Wang YF, Ahmad I.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul 05; 791(1-2):85-92. PubMed ID: 12798168
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determination of irinotecan and its metabolite SN-38 in dried blood spots using high-performance liquid-chromatography with fluorescence detection.
    Hahn RZ, Arnhold PC, Andriguetti NB, Schneider A, Klück HM, Dos Reis SL, Bastiani MF, Kael I, da Silva ACC, Schwartsmann G, Antunes MV, Linden R.
    J Pharm Biomed Anal; 2018 Feb 20; 150():51-58. PubMed ID: 29216585
    [Abstract] [Full Text] [Related]

  • 10. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.
    Rivory LP, Robert J.
    J Chromatogr B Biomed Appl; 1994 Nov 04; 661(1):133-41. PubMed ID: 7866541
    [Abstract] [Full Text] [Related]

  • 11. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    de Bruijn P, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A.
    J Chromatogr B Biomed Sci Appl; 1997 Sep 26; 698(1-2):277-85. PubMed ID: 9367218
    [Abstract] [Full Text] [Related]

  • 12. Clinical pharmacokinetics of irinotecan.
    Chabot GG.
    Clin Pharmacokinet; 1997 Oct 26; 33(4):245-59. PubMed ID: 9342501
    [Abstract] [Full Text] [Related]

  • 13. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D, Chabot GG, Armand JP, Hérait P, Gouyette A, Gandia D.
    J Clin Oncol; 1995 Jan 26; 13(1):210-21. PubMed ID: 7799022
    [Abstract] [Full Text] [Related]

  • 14. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma.
    Owens TS, Dodds H, Fricke K, Hanna SK, Crews KR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May 05; 788(1):65-74. PubMed ID: 12668072
    [Abstract] [Full Text] [Related]

  • 15. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
    Park DJ, Won JH, Cho AR, Yun HJ, Heo JH, Hwhang TH, Lee DH, Kim WM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul 01; 962():147-152. PubMed ID: 24927278
    [Abstract] [Full Text] [Related]

  • 16. Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38.
    Chabot GG.
    Cancer Chemother Pharmacol; 1995 Jul 01; 36(6):463-72. PubMed ID: 7554037
    [Abstract] [Full Text] [Related]

  • 17. Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry.
    Ragot S, Marquet P, Lachâtre F, Rousseau A, Lacassie E, Gaulier JM, Dupuy JL, Lachâtre G.
    J Chromatogr B Biomed Sci Appl; 1999 Dec 24; 736(1-2):175-84. PubMed ID: 10676997
    [Abstract] [Full Text] [Related]

  • 18. Trace analysis of SN-38 in human plasma by high-performance liquid chromatography.
    Rivory LP, Findlay M, Clarke S, Bishop J.
    J Chromatogr B Biomed Sci Appl; 1998 Sep 04; 714(2):355-9. PubMed ID: 9766876
    [Abstract] [Full Text] [Related]

  • 19. Identification and kinetics of a beta-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan.
    Rivory LP, Robert J.
    Cancer Chemother Pharmacol; 1995 Sep 04; 36(2):176-9. PubMed ID: 7767955
    [Abstract] [Full Text] [Related]

  • 20. High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT.
    Kurita A, Kaneda N.
    J Chromatogr B Biomed Sci Appl; 1999 Mar 19; 724(2):335-44. PubMed ID: 10219676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.